一个创新的过程,以高效的自动化优化IMRT基于知识的规划 (KBP)
Ali Yousefi1, Saeedeh Ketabi1, Amy C Moreno2
1Department of Management-Operations Research, University of Isfahan, Isfahan, Iran.
Medical physics
|August 24, 2025
概括
这项研究引入了基于知识的自动化规划 (KBP) 框架和放射治疗的新型缩小技术 (SVSIDB). 自动化方法保持了治疗计划的质量,同时显著减少了计算时间,改善了临床结果.
科学领域:
- 医学物理
- 辐射瘤学
- 计算生物学
背景情况:
- 放射治疗的计划是劳动密集的, 需要专家的调整.
- 自动化和人工智能 (AI) 在简化规划方面表现有前途.
- 现有的方法需要进一步改进以提高精度和效率.
研究的目的:
- 使用数学优化开发一个自动化的IMRT治疗计划方法.
- 为提高计算效率引入两种新的缩小技术.
- 评估拟议方法的计划质量和时间节省.
主要方法:
- 在治疗优化中应用QuadLin及其修订的自动重量调整模型.
- 基于beamlet概念开发了用于voxel集群的SVSIDB算法.
- 使用ABC-K-Means技术进行语音集群.
- 在开放KBP的30名头癌患者数据集中进行了测试.
- 在CVX框架内使用MATLAB和Mosek解决方案进行评估.
主要成果:
- 自动化QuadLin重量实现了与手动分配相美的平面质量.
- 与预测剂量相比,自动化计划提高了临床标准的满足率超过21%.
- 在保持计划质量的同时,SVSIDB减少了50%的解决时间.
- 通过SVSIDB获得了81. 3%的临床标准满意度指数,超过了ABC- K平均值.
- 在节省时间方面,ABC-K-Means的效率与SVSIDB相美.
结论:
- 开发了一个自动化KBP框架和一个高效的缩减技术 (SVSIDB).
- 自动加重维持了治疗计划的质量,与手动调整不同.
- 与之前的研究相比,SVSIDB的质量指数提高了12%.
- 在SVSIDB-QuadLin管道减少了解决时间,并提高了计划质量,而不是完整的数据模型.
相关概念视频
Analysis of Population Pharmacokinetic Data
1.0K
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
1.0K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
335
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
335
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
428
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
428
Pharmacokinetic–Pharmacodynamic Relationship: Problems
129
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
129
Methods of Medium Optimization
74
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
74
Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119


